当前位置： SCI文献检索 > Journal of Neural Engineering期刊下所有文献 > Corrigendum: Tissue-engineered nerve grafts using a scaffold-independent and injectable drug delivery system: a novel design with translational advantages (2019 J. Neural Eng. 16 036030).

Corrigendum: Tissue-engineered nerve grafts using a scaffold-independent and injectable drug delivery system: a novel design with translational advantages (2019 J. Neural Eng. 16 036030).

Abstract：

OBJECTIVE:Currently commercially available nerve conduits have demonstrated suboptimal clinical efficacy in repairing peripheral nerve defects. Although tissue-engineered nerve grafts (TENGs) with sustained release of neurotrophic factors (NTFs) are experimentally proved to be more effective than these blank conduits, there remains a lack of clinical translation. NTFs are typically immobilized onto scaffold materials of the conduit via adsorption, specific binding or other incorporation techniques. These scaffold-based delivery strategies increase complexity and cost of conduit fabrication and lack flexibility in choosing different drugs. Therefore, to facilitate clinical translation and commercialization, we construct a TENG using a scaffold-independent drug delivery system (DDS). APPROACH:This study adopted a scaffold-independent DDS based on methoxy-poly (ethylene glycol)-b-poly(γ-ethyl-Lglutamate) (mPEG-PELG) thermosensitive hydrogels that undergo sol-to-gel transition at body temperature. In addition, TENG, a chitosan scaffold filled with nerve growth factor (NGF)-loaded mPEG-PELG that gel in the lumen upon injection during surgery and function as a drug-releasing conduit-filler, was designed. Subsequently, the efficacy of DDS and therapeutic effects of TENG were assessed. MAIN RESULTS:The results demonstrated that NGFloaded mPEG-PELG controllably and sustainably released bioactive NGF for 28 d. When bridging a 10 mm rat sciatic nerve gap, the morphological, electrophysiological, and functional analyses revealed that NGF-releasing TENG (Scaffold + NGF/mPEG-PELG) achieved superior regenerative outcomes compared to plain scaffolds and those combined with systemic delivery of NGF (daily intramuscular injection (IM)), and its effects were relatively similar to autografts. SIGNIFICANCE:This study has proposed a TENG using thermosensitive hydrogels as an injectable implant to controllably release NGF, which has promising therapeutic potential and translatability. Such TENGs obviate the need for conduit modification, complex preloading or binding mediators, therefore they allow the ease of drug switching in clinical practice and greatly simplify the manufacturing process due to the independent preparation of drug delivery system.

journal_name

J Neural Eng

journal_title

Journal of neural engineering

authors

Liu Y,Yu S,Gu X,Cao R,Cui S

doi

10.1088/1741-2552/abd1ec

subject

Has Abstract

pub_date

2020-12-09 00:00:00

eissn

1741-2560

issn

1741-2552

pub_type

杂志文章

在线工具

Corrigendum: Tissue-engineered nerve grafts using a scaffold-independent and injectable drug delivery system: a novel design with translational advantages (2019 J. Neural Eng. 16 036030).